Table of Contents Author Guidelines Submit a Manuscript
Advances in Virology
Volume 2012, Article ID 205085, 7 pages
http://dx.doi.org/10.1155/2012/205085
Research Article

Association of Active Human Herpesvirus-6, -7 and Parvovirus B19 Infection with Clinical Outcomes in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

1August Kirchenstein Institute of Microbiology and Virology, Riga Stradins University, Ratsupites Street 5, LV-1067 Riga, Latvia
2Department of Infectology and Dermatology, Riga Stradins University, Linezera Street 3, LV-1006 Riga, Latvia
3Department of Neurology and Neurosurgery, Riga Stradins University, Pilsonu Street 13, LV-1002 Riga, Latvia

Received 2 March 2012; Revised 21 June 2012; Accepted 28 June 2012

Academic Editor: Julia G. Prado

Copyright © 2012 Svetlana Chapenko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Fukuda, S. E. Straus, I. Hickie, M. C. Sharpe, J. G. Dobbins, and A. Komaroff, “The chronic fatigue syndrome: a comprehensive approach to its definition and study,” Annals of Internal Medicine, vol. 121, no. 12, pp. 953–959, 1994. View at Google Scholar · View at Scopus
  2. D. V. Ablashi, H. B. Eastman, C. B. Owen et al., “Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients,” Journal of Clinical Virology, vol. 16, no. 3, pp. 179–191, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Chapenko, A. Krumina, S. Kozireva et al., “Activation of human herpesviruses 6 and 7 in patients with chronic fatigue syndrome,” Journal of Clinical Virology, vol. 37, supplement 1, pp. S47–S51, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. M. Lerner, S. H. Beqaj, R. G. Deeter, and J. T. Fitzgerald, “IgM serum antibodies to human cytomegalovirus nonstructural gene products p52 and CM2 (UL44 and UL57) are uniquely present in a subset of patients with chronic fatigue syndrome,” In Vivo, vol. 16, no. 3, pp. 153–159, 2002. View at Google Scholar · View at Scopus
  5. A. M. Lerner, S. H. Beqaj, R. G. Deeter, and J. T. Fitzgerald, “IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome,” In Vivo, vol. 18, no. 2, pp. 101–106, 2004. View at Google Scholar · View at Scopus
  6. A. M. Lerner, S. H. Beqaj, R. G. Deeter, and J. T. Fitzgerald, “Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up,” In Vivo, vol. 21, no. 5, pp. 707–713, 2007. View at Google Scholar · View at Scopus
  7. J. R. Kerr, J. Bracewell, I. Laing et al., “Chronic fatigue syndrome and arthralgia following parvovirus B19 infection,” Journal of Rheumatology, vol. 29, no. 3, pp. 595–602, 2002. View at Google Scholar · View at Scopus
  8. M. Frémont, K. Metzger, H. Rady, J. Hulstaert, and K. De Meirleir, “Detection of herpesviruses and parvovirus B19 in gastric and intestinal mucosa of chronic fatigue syndrome patients,” In Vivo, vol. 23, no. 2, pp. 209–213, 2009. View at Google Scholar · View at Scopus
  9. M. Seishima, Y. Mizutani, Y. Shibuya, and C. Arakawa, “Chronic fatigue syndrome after human parvovirus B19 infection without persistent viremia,” Dermatology, vol. 216, no. 4, pp. 341–346, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. K. S. Chia and A. Y. Chia, “Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach,” Journal of Clinical Pathology, vol. 61, no. 1, pp. 43–48, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. A. S. Bansal, A. S. Bradley, K. N. Bishop, S. Kiani-Alikhan, and B. Ford, “Chronic fatigue syndrome, the immune system and viral infection,” Brain, Behavior, and Immunity, vol. 26, no. 1, pp. 24–31, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. W. C. Reeves, F. R. Stamey, J. B. Black, A. C. Mawle, J. A. Stewart, and P. E. Pellett, “Human herpesviruses 6 and 7 in chronic fatigue syndrome: a case-control study,” Clinical Infectious Diseases, vol. 31, no. 1, pp. 48–52, 2000. View at Publisher · View at Google Scholar · View at Scopus
  13. N. E. Soto and S. E. Straus, “Chronic fatigue syndrome and herpesviruses: the fading evidence,” Herpes, vol. 7, no. 2, pp. 46–50, 2000. View at Google Scholar · View at Scopus
  14. A. L. Komaroff, “Is human herpesvirus-6 a trigger for chronic fatigue syndrome?” Journal of Clinical Virology, vol. 37, supplement 1, pp. S39–S46, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Cameron, L. Flamand, H. Juwana et al., “Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome,” Journal of Medical Virology, vol. 82, no. 10, pp. 1684–1688, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Saiki, T. Kawai, K. Morita et al., “Identification of marker genes for differential diagnosis of chronic fatigue syndrome,” Molecular Medicine, vol. 14, no. 9-10, pp. 599–607, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Bhattacharjee, C. H. Botting, and M. J. Sillanpää, “Bayesian biomarker identification based on marker-expression proteomics data,” Genomics, vol. 92, no. 6, pp. 384–392, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. J. R. Kerr, B. Burke, R. Petty et al., “Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: a detailed analysis of gene networks and clinical phenotypes,” Journal of Clinical Pathology, vol. 61, no. 6, pp. 730–739, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. D. V. Ablashi, N. Balachandran, S. F. Josephs et al., “Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates,” Virology, vol. 184, no. 2, pp. 545–552, 1991. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Santoro, P. E. Kennedy, G. Locatelli, M. S. Malnati, E. A. Berger, and P. Lusso, “CD46 is a cellular receptor for human herpesvirus 6,” Cell, vol. 99, no. 7, pp. 817–827, 1999. View at Google Scholar · View at Scopus
  21. Y. E. Cossart, A. M. Field, B. Cant, and D. Widdows, “Parvovirus like particles in human sera,” The Lancet, vol. 1, no. 7898, pp. 72–73, 1975. View at Google Scholar · View at Scopus
  22. K. E. Brown, S. M. Anderson, and N. S. Young, “Erythrocyte P antigen: cellular receptor for B19 parvovirus,” Science, vol. 262, no. 5130, pp. 114–117, 1993. View at Google Scholar · View at Scopus
  23. M. Söderlund-Venermo, K. Hokynar, J. Nieminen, H. Rautakorpi, and K. Hedman, “Persistence of human parvovirus B19 in human tissues,” Pathologie Biologie, vol. 50, no. 5, pp. 307–316, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Liefeldt, M. Buhl, B. Schweickert et al., “Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy,” Nephrology Dialysis Transplantation, vol. 17, no. 10, pp. 1840–1842, 2002. View at Google Scholar · View at Scopus
  25. L. B. Krupp, N. G. LaRocca, J. Muir-Nash, and A. D. Steinberg, “The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus,” Archives of Neurology, vol. 46, no. 10, pp. 1121–1123, 1989. View at Google Scholar · View at Scopus
  26. P. Secchiero, D. R. Carrigan, Y. Asano et al., “Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction,” Journal of Infectious Diseases, vol. 171, no. 2, pp. 273–280, 1995. View at Google Scholar · View at Scopus
  27. Z. N. Berneman, D. V. Ablashi, G. Li et al., “Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 21, pp. 10552–10556, 1992. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Cavallo, C. Merlino, D. Re et al., “B19 virus infection in renal transplant recipients,” Journal of Clinical Virology, vol. 26, no. 3, pp. 361–368, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Albright, K. Light, A. Light, L. Bateman, and L. A. Cannon-Albright, “Evidence for a heritable predisposition to chronic fatigue syndrome,” BMC Neurology, vol. 11, article 62, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. B. M. Carruthers, M. I. Van de Sande, K. L. De Meirleir et al., “Myalgic encephalomyelitis: international consensus criteria,” Journal of Internal Medicine, vol. 270, no. 4, pp. 327–338, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Patnaik, A. L. Komaroff, E. Conley, E. A. Ojo-Amaize, and J. B. Peter, “Prevalence of IgM antibodies to human herpesvirus 6 early antigen (p41/38) in patients with chronic fatigue syndrome,” Journal of Infectious Diseases, vol. 172, no. 5, pp. 1364–1367, 1995. View at Google Scholar · View at Scopus
  32. D. M. Koelle, S. Barcy, M. L. Huang et al., “Markers of viral infection in monozygotic twins discordant for chronic fatigue syndrome,” Clinical Infectious Diseases, vol. 35, no. 5, pp. 518–525, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Kozireva, G. Nemceva, I. Danilane, O. Pavlova, J. Blomberg, and M. Murovska, “Prevalence of blood-borne viral infections (cytomegalovirus, human herpesvirus-6, human herpesvirus-7, human herpesvirus-8, human T-cell lymphotropic virus-I/II, human retrovirus-5) among blood donors in Latvia,” Annals of Hematology, vol. 80, no. 11, pp. 669–673, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Ihira, T. Yoshikawa, K. Suzuki et al., “Monitoring of active HHV-6 infection in bone marrow transplant recipients by real time PCR; comparison to detection of viral DNA in plasma by qualitative PCR,” Microbiology and Immunology, vol. 46, no. 10, pp. 701–705, 2002. View at Google Scholar · View at Scopus
  35. P. Lusso, “HHV-6 and the immune system: mechanisms of immunomodulation and viral escape,” Journal of Clinical Virology, vol. 37, supplement 1, pp. S4–S10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. J. R. Kerr and D. A. J. Tyrrell, “Cytokines in parvovirus B19 infection as an aid to understanding chronic fatigue syndrome,” Current Pain and Headache Reports, vol. 7, no. 5, pp. 333–341, 2003. View at Google Scholar · View at Scopus
  37. M. A. Fletcher, X. R. Zeng, Z. Barnes, S. Levis, and N. G. Klimas, “Plasma cytokines in women with chronic fatigue syndrome,” Journal of Translational Medicine, vol. 7, article 96, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. U. Vollmer-Conna, B. Cameron, D. Hadzi-Pavlovic et al., “Postinfective fatigue syndrome is not associated with altered cytokine production,” Clinical Infectious Diseases, vol. 45, no. 6, pp. 732–735, 2007. View at Publisher · View at Google Scholar · View at Scopus